{"organizations": [], "uuid": "fe312136b6568481755e4263d80614742318b01b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-vitrolife-buys-licensing-rights-fo/brief-vitrolife-buys-licensing-rights-for-embryo-transfer-technology-idUSASM000I0L", "country": "US", "domain_rank": 408, "title": "BRIEF-Vitrolife buys licensing rights for embryo transfer technology", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.237, "site_type": "news", "published": "2018-01-11T15:35:00.000+02:00", "replies_count": 0, "uuid": "fe312136b6568481755e4263d80614742318b01b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-vitrolife-buys-licensing-rights-fo/brief-vitrolife-buys-licensing-rights-for-embryo-transfer-technology-idUSASM000I0L", "ord_in_thread": 0, "title": "BRIEF-Vitrolife buys licensing rights for embryo transfer technology", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - Vitrolife AB:\n* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER\n* SAYS ‍INTENDS TO COMMERCIALISE TECHNOLOGY BY MARKETING A UNIQUE EMBRYO TRANSFER CATHETER​\n* SAYS ‍INITIAL PURCHASE PRICE AMOUNTED TO USD 5 MILLION​ * SAYS ‍ACQUISITION IS EXPECTED TO IMPACT EBITDA PER SHARE MARGINALLY NEGATIVELY DURING 2018-2020 AND POSITIVELY AS FROM 2021​ Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T15:35:00.000+02:00", "crawled": "2018-01-12T18:37:38.002+02:00", "highlightTitle": ""}